• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-苯丁酸通过调节破骨细胞自噬来防止脂多糖诱导的骨丢失。

4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts.

机构信息

Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.

Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea; Department of Pathology, Ulsan University Hospital, Ulsan 682-714, Republic of Korea.

出版信息

Biochem Pharmacol. 2018 May;151:9-17. doi: 10.1016/j.bcp.2018.02.019. Epub 2018 Feb 16.

DOI:10.1016/j.bcp.2018.02.019
PMID:29458048
Abstract

4-Phenylbutyric acid (4-PBA) has been used clinically to treat urea cycle disorders and is known to be an inhibitor of endoplasmic reticulum (ER) stress. We hypothesized that 4-PBA attenuates inflammatory bone loss by inducing autophagy, a process that is frequently accompanied by ER stress. Micro computerized tomography analysis showed that 4-PBA attenuated LPS-induced bone loss in mice. The increased area of TRAP-positive osteoclasts (OCs) and serum level of collagen type I fragments in lipopolysaccharide (LPS)-treated mice were also decreased when 4-PBA was administered, suggesting a protective role of 4-PBA in OCs. In vitro, 4-PBA significantly reduced OC area without affecting the number of OCs induced by LPS and decreased bone resorption upon LPS stimulation. LPS-induced autophagy was attenuated by 4-PBA in OCs, as demonstrated by reduced LC3II accumulation, increased p62 level, and reduction in AVO-containing cells. Silencing of autophagy-related protein 7 attenuated the effects of 4-PBA on OC size and fusion. Moreover, 4-PBA reduced nuclear factor-κB (NF-κB) DNA binding upon LPS stimulation of OCs. Inhibition of NF-κB activation diminished the inhibitory effect of 4-PBA on LPS-stimulated changes in LC3II level, OC area, and OC fusion, implying that the effects of 4-PBA on OCs are due at least in part to inhibition of NF-κB. These data demonstrate that 4-PBA attenuates LPS-induced bone loss by reducing autophagy in OCs. Our data highlight the therapeutic potential of 4-PBA for ameliorating inflammatory bone loss.

摘要

4- 苯基丁酸(4-PBA)已被临床用于治疗尿素循环障碍,并且已知其是内质网(ER)应激的抑制剂。我们假设 4-PBA 通过诱导自噬来减轻炎症性骨丢失,自噬是一种经常伴随 ER 应激的过程。微计算机断层扫描分析表明,4-PBA 可减轻 LPS 诱导的小鼠骨丢失。当给予 4-PBA 时,还降低了 LPS 处理的小鼠中 TRAP 阳性破骨细胞(OC)的增加面积和胶原 I 片段的血清水平,这表明 4-PBA 在 OC 中具有保护作用。在体外,4-PBA 可显著减少 OC 面积,而不影响 LPS 诱导的 OC 数量,并减少 LPS 刺激时的骨吸收。4-PBA 减弱了 LPS 诱导的 OC 中的自噬,表现为 LC3II 积累减少,p62 水平增加,并且含有 AVO 的细胞减少。自噬相关蛋白 7 的沉默减弱了 4-PBA 对 OC 大小和融合的影响。此外,4-PBA 降低了 LPS 刺激 OC 时核因子-κB(NF-κB)DNA 结合。抑制 NF-κB 激活减弱了 4-PBA 对 LPS 刺激的 LC3II 水平、OC 面积和 OC 融合变化的抑制作用,表明 4-PBA 对 OC 的作用至少部分归因于 NF-κB 的抑制。这些数据表明,4-PBA 通过减少 OC 中的自噬来减轻 LPS 诱导的骨丢失。我们的数据突出了 4-PBA 用于改善炎症性骨丢失的治疗潜力。

相似文献

1
4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts.4-苯丁酸通过调节破骨细胞自噬来防止脂多糖诱导的骨丢失。
Biochem Pharmacol. 2018 May;151:9-17. doi: 10.1016/j.bcp.2018.02.019. Epub 2018 Feb 16.
2
Lycorine Attenuates Autophagy in Osteoclasts via an Axis of mROS/TRPML1/TFEB to Reduce LPS-Induced Bone Loss.冬凌草甲素通过 mROS/TRPML1/TFEB 轴抑制破骨细胞自噬减少 LPS 诱导的骨丢失。
Oxid Med Cell Longev. 2019 Oct 8;2019:8982147. doi: 10.1155/2019/8982147. eCollection 2019.
3
4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models.在急性肺损伤模型中,4-苯基丁酸通过调节内质网应激和自噬来抑制脂多糖诱导的炎症反应。
Toxicol Lett. 2017 Apr 5;271:26-37. doi: 10.1016/j.toxlet.2017.02.023. Epub 2017 Feb 27.
4
Anti-inflammatory, anti-osteoclastic, and antioxidant activities of genistein protect against alveolar bone loss and periodontal tissue degradation in a mouse model of periodontitis.染料木黄酮具有抗炎、抗破骨细胞和抗氧化活性,可防止牙周炎小鼠模型中牙槽骨丢失和牙周组织降解。
J Biomed Mater Res A. 2017 Sep;105(9):2510-2521. doi: 10.1002/jbm.a.36109. Epub 2017 Jun 6.
5
Autophagy negative-regulating Wnt signaling enhanced inflammatory osteoclastogenesis from Pre-OCs in vitro.自噬负调控 Wnt 信号增强体外 Pre-OCs 炎症破骨细胞生成。
Biomed Pharmacother. 2020 Jun;126:110093. doi: 10.1016/j.biopha.2020.110093. Epub 2020 Mar 18.
6
Lipopolysaccharide (LPS)-Induced Autophagy Is Responsible for Enhanced Osteoclastogenesis.脂多糖(LPS)诱导的自噬负责增强破骨细胞生成。
Mol Cells. 2017 Nov 30;40(11):880-887. doi: 10.14348/molcells.2017.0230. Epub 2017 Nov 16.
7
The regulatory mechanism of 4-phenylbutyric acid against ER stress-induced autophagy in human gingival fibroblasts.4- 苯基丁酸对人牙龈成纤维细胞内质网应激诱导自噬的调控机制。
Arch Pharm Res. 2012 Jul;35(7):1269-78. doi: 10.1007/s12272-012-0718-2. Epub 2012 Aug 3.
8
Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors.半胱氨酸蛋白酶抑制剂在体外和体内对脂多糖诱导的破骨细胞形成和骨吸收的抑制作用。
J Leukoc Biol. 2017 May;101(5):1233-1243. doi: 10.1189/jlb.3A1016-433R. Epub 2017 Feb 14.
9
Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.集落刺激因子 1 受体抑制通过抑制破骨细胞形成来预防脂多糖诱导的骨质疏松症。
Biomed Pharmacother. 2019 Jul;115:108916. doi: 10.1016/j.biopha.2019.108916. Epub 2019 May 1.
10
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo.溴化噻唑鎓盐在体外抑制RANKL诱导的破骨细胞形成和骨吸收,并在体内预防LPS诱导的骨质流失。
Biochem Pharmacol. 2016 Mar 15;104:118-30. doi: 10.1016/j.bcp.2016.02.013. Epub 2016 Feb 21.

引用本文的文献

1
4-Phenyl Butyric Acid (4-PBA) Suppresses Neutrophil Recruitment in a Murine Model of Acute Perinatal Inflammation.4-苯基丁酸(4-PBA)抑制急性围产期炎症小鼠模型中的中性粒细胞募集。
J Immunol Res. 2025 Jul 7;2025:2438058. doi: 10.1155/jimr/2438058. eCollection 2025.
2
IDO1 induced macrophage M1 polarization via ER stress-associated GRP78-XBP1 pathway to promote ulcerative colitis progression.吲哚胺2,3-双加氧酶1通过内质网应激相关的葡萄糖调节蛋白78- X盒结合蛋白1途径诱导巨噬细胞M1极化,以促进溃疡性结肠炎进展。
Front Med (Lausanne). 2025 Apr 30;12:1524952. doi: 10.3389/fmed.2025.1524952. eCollection 2025.
3
Butyrolactone-I from Marine Fungal Metabolites Mitigates Heat-Stress-Induced Apoptosis in IPEC-J2 Cells and Mice Through the ROS/PERK/CHOP Signaling Pathway.
来自海洋真菌代谢产物的丁内酯-I通过ROS/PERK/CHOP信号通路减轻热应激诱导的IPEC-J2细胞和小鼠细胞凋亡。
Mar Drugs. 2024 Dec 17;22(12):564. doi: 10.3390/md22120564.
4
Zoledronic Acid Inhibits Lipopolysaccharide-Induced Osteoclastogenesis by Suppressing Macrophage NLRP3-Mediated Autophagy Pathway.唑来膦酸通过抑制巨噬细胞NLRP3介导的自噬途径来抑制脂多糖诱导的破骨细胞生成。
Immun Inflamm Dis. 2024 Dec;12(12):e70094. doi: 10.1002/iid3.70094.
5
mA modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis.mA 修饰的脂酰基辅酶 A 转移酶 1 通过激活铜死亡抑制膀胱癌进展。
Oncogene. 2024 Sep;43(40):2971-2985. doi: 10.1038/s41388-024-03139-5. Epub 2024 Aug 28.
6
Pharmacological inhibition of endoplasmic reticulum stress mitigates osteoporosis in a mouse model of hindlimb suspension.内质网应激的药理学抑制减轻了后肢悬吊小鼠模型的骨质疏松症。
Sci Rep. 2024 Feb 27;14(1):4719. doi: 10.1038/s41598-024-54944-7.
7
The role of autophagy in SIM mediated anti-inflammatory osteoclastogenesis through NLRP3 signaling pathway.自噬在 SIM 通过 NLRP3 信号通路介导的抗炎破骨细胞发生中的作用。
Immun Inflamm Dis. 2024 Jan;12(1):e1145. doi: 10.1002/iid3.1145.
8
Regulatory Role of circRNA-0067835 in Behcet Disease through Targeting Micro RNA-155: Implication of and .环状RNA-0067835通过靶向微小RNA-155在白塞病中的调控作用:[此处可能缺失部分内容]及[此处可能缺失部分内容]的意义
Rep Biochem Mol Biol. 2023 Apr;12(1):195-204. doi: 10.52547/rbmb.12.1.195.
9
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.RUNX1 抑制剂与吉西他滨联合通过调节 BiP/PERK/eIF2α 轴介导的内质网应激减轻胰腺导管腺癌的化疗耐药性。
J Exp Clin Cancer Res. 2023 Sep 11;42(1):238. doi: 10.1186/s13046-023-02814-x.
10
Strontium Ranelate Inhibits Osteoclastogenesis through NF-κB-Pathway-Dependent Autophagy.雷奈酸锶通过依赖NF-κB途径的自噬抑制破骨细胞生成。
Bioengineering (Basel). 2023 Mar 16;10(3):365. doi: 10.3390/bioengineering10030365.